Which substance may be used to treat anemia caused by chronic kidney disease?

The treatment of anemia associated with chronic kidney disease often involves the use of erythropoietin. Erythropoietin is a hormone produced by the kidneys that stimulates the production of red blood cells in the bone marrow. In cases of chronic kidney disease, the kidneys may be unable to produce sufficient amounts of this hormone, leading to a deficiency and resulting anemia. Therefore, administering erythropoietin can help correct this deficiency by promoting red blood cell production, thus alleviating anemia.

While hematinics, iron supplements, and corticosteroids can play roles in managing various types of anemia, they are not specifically geared toward the underlying issue presented by chronic kidney disease. Hematinics are generally used to increase hemoglobin levels but do not address the hormonal aspect of erythropoiesis in chronic kidney disease. Iron supplements are typically used when anemia is due to an iron deficiency rather than a lack of erythropoietin. Corticosteroids may be employed in other conditions but are not a primary treatment for anemia related to kidney dysfunction.